AI-Enhanced Peptide Design Tools for Novel Peptides & Optimization

This review highlights AI's potential in pioneering novel peptide designs and refining existing molecular structures for high-quality peptide development.

• Revolutionizing peptide generation and optimization
• Uses deep learning frameworks like RFdiffusion for de novo design
• Focus on cyclic cell-targeting peptides with high tumor affinity

De Novo Peptide Sequencing with AI: InstaNovo & InstaNovo+

Introduces transformer-based and diffusion-based AI models for de novo peptide sequencing from mass spectrometry data, greatly enhancing accuracy.

• Significantly improves peptide sequencing accuracy
• Expands discovery of novel biomolecules
• Enables high-precision sequencing of nanobodies and complex samples

AI-Driven Antimicrobial Peptide (AMP) Discovery & Generation

Explores the application of AI in discovering AMPs by mining biological sequences and generating novel peptide sequences with optimal therapeutic properties.

• Efficiently navigates vast sequence space for AMPs
• Identifies peptides with desired properties and reduced toxicity
• Leverages generative models for new sequences

AI for Predicting Peptide Properties in Mass Spectrometry

Reviews state-of-the-art machine learning and deep learning models for predicting peptide properties in mass spectrometry-based proteomics.

• Predicts digestibility, retention time, charge state
• Enables in silico generation of spectral libraries
• Crucial for accurate peptide identification in proteomics

AI in Accelerating Overall Peptide Drug Discovery Pipeline

Highlights how AI, including machine learning and deep learning, is transforming and accelerating the entire peptide drug discovery pipeline.

• Enables in silico discovery of new peptide ligands
• Predicts peptide-protein interactions effectively
• Accelerates early identification of lead candidates

AI for Designing Highly Active Peptides and Optimizing Bioactivity

Describes how machine learning greatly assists in designing highly active peptides by learning predictors from existing data, reducing the need for extensive lab experiments.

• Efficiently identifies peptides with best predicted bioactivity
• Uses properties like k-mer criteria and physicochemical properties
• Partly replaces expensive laboratory experiments

AI Methods for Antimicrobial Peptides: Progress and Challenges

Covers recent advancements in using large protein language models and graph neural networks via AI to address challenges in AMP discovery and design.

• Addresses toxicity and poor stability of AMPs
• Utilizes structure-guided design via AI
• Accelerates translation of AMPs into clinical use

Large Language Models (LLMs) for Re-engineering Peptide Antibiotics

Researchers successfully leveraged LLMs to re-engineer existing bacteria-killing peptides to be safe for human use while retaining efficacy.

• Optimizes peptide properties for safety and potency
• Demonstrates LLMs' power in navigating chemical space
• Focuses on re-engineering for human compatibility

AI for Accelerated & Efficient Antimicrobial Peptide Design

A deep learning approach significantly accelerates antimicrobial peptide design, achieving high accuracy in predicting AMP efficacy and reducing time and cost.

• Converts peptide features into "signal images" for neural networks
• Improves feature extraction and AMP categorization
• Achieves substantial time and cost reductions in design

AI in Drug Discovery: Key Trends Shaping Therapeutics in 2025

Highlights how AI-driven drug discovery is revolutionizing peptide-based drug discovery, enabling rapid design, activity prediction, and optimization of novel therapeutics.

• Enables rapid design and activity prediction
• Integrates AlphaFold and generative models like proteinMPNN
• Focuses on high-potency peptide drug candidates

AI for Interpreting Peptide Biological & Chemical Representations

This study examines the influence of different peptide representations on AI prediction models' interpretability and accuracy, developing "feature attribution" methodologies.

• Develops methodologies for local interpretability
• Elucidates intrinsic mechanisms of peptide activities
• Enhances accuracy of AI prediction models

Generative AI for Self-Assembling Peptides (SAP) Discovery

Presents a generative AI model that is 80-95% accurate in the discovery of self-assembling peptides, marking a significant step in "intelligent laboratories" for material discovery.

• Outperforms current state-of-the-art SAP models
• Efficiently explores complex sequence space of SAPs
• Advances accelerated material discovery

AI in Peptide-Based Vaccine Design

This review details how AI, especially machine learning algorithms, is transforming peptide-based vaccine design by predicting T-cell epitopes and optimizing immunogenicity.

• Predicts T-cell epitopes effectively
• Optimizes peptide immunogenicity for vaccines
• Accelerates identification of promising vaccine candidates

Machine Learning for Predicting Cell-Penetrating Peptides (CPPs)

Focuses on machine learning applications for predicting and rationally designing cell-penetrating peptides, crucial for advanced peptide drug delivery.

• Predicts CPP efficacy and cellular uptake mechanisms
• Enables rational design of peptide drug delivery systems
• Crucial for improving therapeutic bioavailability

Deep Learning for De Novo Design of Therapeutic Peptides

Researchers are utilizing deep learning frameworks for the de novo design of peptides with specific therapeutic properties, generating novel sequences from scratch.

• Generates novel peptide sequences with desired activities
• Significantly expands chemical space for drug discovery
• Aims for properties like enzyme inhibition or receptor binding

AI for Enhanced Peptide Synthesis & Process Optimization

Explores the application of AI in optimizing peptide synthesis processes, including predicting reaction yields and streamlining experimental workflows.

• Predicts reaction yields and side-product formation
• Improves overall efficiency and scalability of manufacturing
• Reduces waste in peptide production

AI-Driven Prediction of Peptide Self-Assembly

This review summarizes the use of machine learning models to predict the self-assembly behavior of peptides, critical for designing peptide-based biomaterials and nanostructures.

• Aids in understanding and controlling self-assembly factors
• Enables rational design of functional peptide materials
• Critical for peptide-based biomaterials and nanostructures

Graph Neural Networks (GNNs) for Peptide-Protein Interaction Prediction

Details the application of GNNs for highly accurate prediction of peptide-protein interactions, capturing complex structural and chemical features for drug design.

• Captures complex structural and chemical features
• Leads to robust predictions of binding affinity and specificity
• Crucial for drug design and understanding biological pathways

AlphaFold2 Peptide Structure Prediction

This figure showcases the accuracy of AlphaFold2 in predicting peptide structures, comparing its models to experimentally determined NMR structures.

Greening the Synthesis of Peptide Therapeutics

This infographic highlights strategies for reducing the environmental footprint of solid-phase peptide synthesis (SPPS) in industrial settings.

Peptide and Protein Bioanalysis

An informative visual explaining the challenges and solutions in analyzing large biomolecules like peptides and proteins in bioanalytical laboratories.

Peptides: What They Are and Why They Are Useful

This infographic provides an overview of peptides, their functions in the body, and their applications in skincare and muscle repair.

Detailed Glycine-Lysine-Tyrosine-Alanine Peptide Bond Diagram

A detailed diagram illustrating the peptide bonds between glycine, lysine, tyrosine, and alanine, highlighting the structure of the peptide chain.

Global Peptide Therapeutics Market Report Infographic

This infographic presents data on the global market size and growth trends for peptide therapeutics, providing insights into industry dynamics.

New Trends in Peptide Therapies: Oral Peptides for Neurosciences

Advances in bioengineering and genetic code expansion are leading to a new era of oral peptide therapeutics for neuropsychiatric disorders, with many now in clinical trials.

Sethera Therapeutics: Enhancing Peptide Stability for Oral Drugs

Sethera is bioengineering peptides for increased stability, enabling longer-lasting treatments and potential oral delivery for conditions like diabetes and obesity, previously considered untreatable.

Antimicrobial Peptides: AI-Driven Design for Bacterial Keratitis

Cutting-edge advancements in antimicrobial peptide (AMP) modification strategies and AI-assisted design are enhancing their efficacy and stability, offering new hope against bacterial keratitis.

Innovations in Peptide Engineering & Novel Delivery Systems

Recent breakthroughs in peptide engineering, including cyclization, PEGylation, and advanced delivery methods like nanocarriers, are significantly boosting the therapeutic potential of peptides across various diseases.

Broadening the Scope: New Peptide Therapeutics for Diverse Conditions

New synthesis and modification technologies are diversifying peptide drug development, enabling their application to a wider range of clinical conditions, from cancer to metabolic disorders.

Chemical Biology Tools Advancing Peptide & Protein Research

New chemical biology tools are proving critical for site-specific modification, understanding biomolecule interactions, and developing better intracellular delivery systems for peptide-based therapeutics.

Foundational & Advanced Synthetic Peptide Chemistry

Continuous refinements in peptide chemistry, including native chemical ligation (NCL), remain crucial for the precise and efficient synthesis of complex and larger peptide and protein targets.

Computational Approaches Revolutionize Bioactive Peptide Discovery

Bioinformatics techniques like computer simulation screening, QSAR analysis, and machine learning are dramatically improving the efficiency of discovering and identifying novel bioactive peptides.

Bioactive Peptides: Functional Properties in Food Science

Recent research highlights the production and characterization of bioactive peptides from food sources, exploring their diverse health benefits and strategies to enhance their stability and bioavailability.

Clinical Success: Tirzepatide Outperforms Semaglutide for Weight Loss

A significant New England Journal of Medicine study reports that the peptide-based GLP-1/GIP receptor agonist, tirzepatide, shows superior results for weight loss compared to semaglutide.

The Expanding World of Peptide Engineering Across Disciplines

Peptide engineering is rapidly growing, integrating advancements in synthesis, drug delivery, and materials science to create innovative applications in medicine, biotechnology, and nanotechnology.

Peptide Synthesis: Enabling Diverse Therapeutic & Research Peptides

Ongoing development and refinement of solid-phase peptide synthesis (SPPS) and other methods are fundamental for producing the diverse array of synthetic peptides critical for current research and therapeutics.